Authors
Latest:
Glaucoma & ocular surface preservation: Key factors for ODs to considerKnow options for treatment are available
Latest:
AI and the modern optometric practice restartNew systems, digital front desks, and analytics help ODs reinvent practice management plans
Latest:
EyeCon 2024: Kelly Nichols, OD, and A. Paul Chous, OD, discuss multidisciplinary care and AI in diabetes managementKelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, co-chairs of EyeCon 2024, discussed the first day of the conference, which featured talks on thyroid eye disease, refractive technologies, and red flags in patient care.
Latest:
What to look out for and how to treat central serous chorioretinopathyWilliam Hogue, OD, MS, sat down with Optometry Times to outline what symptoms and risk factors eye care providers should look out for in identifying central serous chorioretinopathy in their patients, as well as what treatment options are available.
Latest:
Efficiency of physiotherapy in treating and preventing uncomplicated acquired myopiaAn inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.
Latest:
DED: Developing a 360° diagnosis and treatment planModern technology enables early detection, individualized solutions.
Latest:
Achieving improved outcomes through partnerships between optometrists and retina specialistsConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
What’s your clinical protocol for managing diabetic retinopathy?A task force of eye care providers is asking for feedback on newly-developed guidelines for managing diabetic retinopathy in their patients.
Latest:
AAOpt 2023: Navigating the evolution of glaucoma and MIGSGleb Sukhovolskiy discusses his 2023 AAOpt presentation, "Optometrist’s Guide to MIGS and the Continuing Evolution of Glaucoma Treatment."
Latest:
Contact lens disinfection methods still matterLong-term success of contact lens wearers attributed to education, professional input on cleaning methods
Latest:
A closer look at AI utilization with electronic health record systemsAmbient listening and transcription provide promising impact on the patient care experience.
Latest:
AAOpt 2022: Genetic testing in AMDBrad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Genetic testing in AMD: critical, useful, or inappropriate," which he presented during the 2022 American Academy of Optometry meeting.
Latest:
New tools emerge for the early detection of hydroxychloroquine maculopathyRapid macular thinning often precedes traditional symptoms.
Latest:
Inside the overlap between scleral lenses and dry eyeChoosing the best lens is a puzzle that requires consideration of all the pieces.
Latest:
Brainstorming eye care research expansion with unlimited resourcesFrom contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Latest:
Review Duane’s retraction syndrome diagnosis and treatmentUnderstand the condition’s structural, innervational, neurological, and genetic abnormalities
Latest:
Offer patients new contact lens technology: 4 Keys to successOne OD has polished a 4 step process of introducing new contact lens technology to patients
Latest:
Pediatric vision and digital media: A bad combinationResearch indicates that too much technology usage results in negative effects on eyesight.
Latest:
The vitreous—remember me?Watching out for inevitable degenerative changes can improve patient care.
Latest:
OCT, OCTA show promise in screening for DRThis imaging technique provides depth-resolved images of retinal vasculature.
Latest:
Transcript: Find out more about Allergan’s presbyopia drop NDA filingPotential presbyopia treatment coming
Latest:
Unlock the secrets of the myopic eyeWhat axial length readings and crystalline lens power tell you.
Latest:
VEW 2023: Phase 3 BRIO-I data for brimochol PF for presbyopiaBen Bergo, CEO of Visus, shares data from the company's pivotal phase 3 BRIO-1 trial, as well as answers questions about Brimochol PF.
Latest:
Approach patients with low vision on an individual basisClinicians must think creatively for solutions to vocational rehabilitation
Latest:
EnVision Summit 2024: How women in eye care can navigate a personal IPO journeyMarsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.
Latest:
The Myopia Collective: AOA, CooperVision unveil exciting new collaborationMichele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.
